News

Filter

Current filters:

Macugen

1 to 9 of 53 results

Valeant bags another company, Eyetech

14-02-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has agreed…

BiotechnologyEyetechMacugenMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

Merck & Co gets EU approval for Victrelis; Pfizer withdraws Macugen indication extension

20-07-2011

US drug giant Merck & Co (NYSE: MRK) says that the European Commission has approved Victrelis (boceprevir)…

Anti-viralsEuropeMacugenMerck & CoOphthalmicsPfizerPharmaceuticalRegulationVictrelis

Novartis will pay towards Lucentis in UK

01-09-2008

Swiss drug major Novartis has successfully persuaded the UK's National Institute for Health and Clinical…

LucentisMacugenNovartisPegaptanib SodiumPfizerRanibizumab Injection

UK's NICE to finalize approval of Lucentis

07-04-2008

The National Institute for Health and Clinical Excellence's (NICE) Final Appraisal Document on anti-vascular…

Amino AcidsInjectionLucentisMacugenNovartisPegaptanib SodiumPfizerPhysostigmine SalicylateRanibizumab Injection

1 to 9 of 53 results

COMPANY SPOTLIGHT

Menarini

Back to top